ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974

Abstracts From AACR Annual Meeting

May 21, 1976

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009